Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia

Eur J Haematol. 2023 Jun;110(6):778-779. doi: 10.1111/ejh.13954. Epub 2023 Mar 23.

Authors

Edgar Ulises Coronado-Alejandro¹, Juan Pablo Martínez-Hernández¹, Andrés Gómez-De León¹, Perla Rocío Colunga-Pedraza¹, José Carlos Jaime-Pérez¹, Olga Graciela Cantú-Rodríguez¹, César Homero Gutiérrez-Aguirre¹, David Gómez-Almaguer¹

Affiliation

¹ Hematology Service, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico.

PMID: 36919276
DOI: 10.1111/ejh.13954

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived
Dexamethasone / adverse effects
Humans
Purpura, Thrombocytopenic, Idiopathic* / diagnosis
Purpura, Thrombocytopenic, Idiopathic* / drug therapy
Rituximab
Thrombocytopenia*

Substances

Rituximab
Dexamethasone
Antibodies, Monoclonal, Murine-Derived